Plain-English translation of NCT06682819 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is looking for chemical clues in your blood and tears that might help doctors understand Leber hereditary optic neuropathy (NOHL) — a genetic eye condition that can cause vision loss. Researchers want to compare the chemical profiles of people who carry the genetic mutation for this disease with and without changes in their eye nerve layer, and also compare them to people without the mutation.
NOHL affects many more men than women, and doctors don't yet fully understand why some people with the genetic mutation develop eye problems while others don't. This study hopes to find chemical signatures in blood and tears that might explain these differences and eventually help predict who is at risk.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital for an eye imaging scan (OCT) to measure your optic nerve thickness, and researchers will collect small samples of your blood and tears. The study compares chemical profiles between men and women separately, so results are analyzed by gender. The visits should be relatively brief, though the exact number and timing of visits is not detailed in the current information.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France